lactat
dehydrogenaseelev
viru
ldv
seem
ideal
persist
viru
sens
invari
establish
lifelong
virem
infect
mice
regardless
strain
age
sex
escap
host
defens
mechan
without
caus
signific
harm
host
review
see
product
cytocid
replic
ldv
restrict
subpopul
resid
macrophag
present
practic
tissu
permiss
macrophag
continu
renew
lymphoid
tissu
liver
testi
support
persist
infect
subpopul
macrophag
seem
nonessenti
host
function
clear
lactat
dehydrogenas
ldh
circul
continu
destruct
subpopul
result
fiveto
tenfold
elev
plasma
ldh
level
henc
name
ldv
ldv
establish
persist
infect
spite
highli
cytocid
viru
infect
macrophag
releas
infecti
unit
within
h
post
infect
pi
high
titer
antildv
antibodi
gener
within
week
pi
neutral
antibodi
appear
month
pi
neutral
viral
infect
demonstr
vitro
ineffici
antildv
cytotox
cell
also
gener
rapidli
disappear
day
pi
restimul
persist
infect
mice
throughout
infect
larg
amount
viru
accumul
newli
form
germin
center
spleen
lymph
node
coincident
polyclon
activ
b
cell
result
perman
elev
plasma
format
autoantibodi
low
molecular
weight
immun
complex
persist
infect
abil
mice
mount
primari
secondari
antigenspecif
humor
immun
respons
slightli
reduc
factor
limit
success
ldv
viru
rel
ineffici
transmiss
mice
ldv
belong
new
asyetunnam
famili
positivestrand
rna
virus
present
classifi
genu
arteriviru
member
famili
equin
arter
viru
eav
porcin
reproduct
respiratori
syndrom
viru
prrsv
simian
hemorrhag
fever
viru
shfv
member
group
envelop
virus
possess
diamet
nm
rel
smooth
surfac
spheric
nucleocapsid
core
diamet
nm
see
also
fig
nucleocapsid
compos
linear
singlestrand
polyadenyl
rna
posit
polar
nucleocapsid
protein
n
envelop
contain
nonglycosyl
protein
one
primari
glycoprotein
kda
one
minor
glycoprotein
similar
size
see
fig
later
gener
organ
express
genom
group
virus
eg
fig
ldv
resembl
coronavirus
genom
express
involv
format
cotermin
nest
set
six
seven
subgenom
mrna
mrna
four
virus
see
fig
one
addit
mrna
ldv
subgenom
mrna
carri
noncod
leader
nucleotid
nt
deriv
end
viral
genom
noncod
segment
end
polyadenyl
fig
leader
becom
join
bodi
subgenom
mrna
within
upstream
singl
specif
short
nucleotid
sequenc
heptanucleotid
case
ldv
end
join
bodi
subgenom
mrna
complet
partial
homolog
segment
preced
open
read
frame
orf
howev
mechan
format
subgenom
mrna
elucid
see
subgenom
mrna
like
express
singl
protein
encod
orf
fig
orf
overlap
variou
extent
neighbor
nt
orf
read
altern
frame
sequenc
analys
genom
two
strain
ldv
ldvc
ldvp
singl
strain
eav
prrsv
allow
identif
code
sequenc
nonstructur
structur
protein
virus
eg
ldvp
fig
conclus
conform
envelop
protein
virion
envelop
fig
nucleocapsid
protein
four
virus
encod
r
orf
see
fig
n
protein
phosphoprotein
similar
size
amino
acid
see
later
tabl
highli
basic
pi
probabl
facilit
interact
genom
rna
assembl
nucleocapsid
structur
resembl
coronaviru
protein
possess
three
close
adjac
transmembran
segment
near
ntermin
end
ntermin
probabl
function
uncleav
signal
sequenc
fig
postul
ntermin
ectodomain
protein
virus
short
amino
acid
orf
protein
shown
primari
envelop
glycoprotein
eav
gl
l
larg
orf
protein
second
minor
envelop
glycoprotein
g
small
appli
ldv
correspond
ldv
protein
tent
design
respect
size
fig
orf
protein
virus
exhibit
similar
structur
uniqu
major
viral
envelop
glycoprotein
predict
travers
lipid
bilay
three
time
also
expos
rel
short
ectodomaln
see
fig
case
ldv
prrsv
segment
amino
acid
one
three
potenti
nglycosyl
site
would
project
extern
cleavag
signal
peptid
fig
ib
might
explain
smooth
appear
outer
surfac
virion
seen
electron
micrograph
ectodomain
gl
eav
somewhat
larger
amino
acid
unusu
larg
oligosaccharid
side
chain
link
nglycosyl
site
ectodomain
ldv
gl
eav
identifi
polylactosaminoglycan
similar
nb
protein
influenza
b
viru
presenc
larg
heterogen
polylactosaminoglycan
explain
heterogen
size
protein
orf
protein
convent
envelop
glycoprotein
possess
signal
pepfid
ctermin
transmembran
segment
one
four
potenti
nglycosyl
site
fig
polyclon
monoclon
antibodi
neutral
ldv
eav
vitro
direct
toward
gl
respect
probabl
epitop
locat
ectodomain
glycoprotein
see
fig
ldv
virion
gl
eav
virion
de
vri
person
commun
link
disulfid
bond
probabl
involv
singl
cy
residu
ectodomain
two
protein
conserv
virus
group
see
fig
breakag
disulfid
bond
result
complet
inactiv
ldv
infect
result
combin
specif
neutral
antibodi
suggest
disulfidelink
ectodomain
form
site
attach
ldv
cell
surfac
receptor
contrast
rel
larg
endodomain
fig
amino
acid
may
play
role
direct
bud
nucleocapsid
intern
space
cytoplasm
membran
vesicl
see
fig
structur
two
major
envelop
protein
group
virus
linkag
disulfid
bond
fig
uniqu
among
virus
function
nonstructur
orf
orf
glycoprotein
unknown
largest
subgenom
mrna
fig
uniqu
ldv
carri
end
orf
lb
potenti
encod
acid
protein
whether
protein
express
infect
cell
clear
end
genom
virus
group
kb
see
fig
encod
two
larg
protein
la
amino
acid
lb
amino
acid
orf
lb
protein
express
via
frameshift
mechan
orf
lalb
protein
possess
sever
function
motif
fig
papainlik
cystein
proteinas
pcp
serin
proteinas
motif
orf
la
protein
replicas
helicas
zinc
finger
motif
orf
lb
protein
cleav
function
unit
virion
proteinas
ntermin
end
eav
orf
la
protein
possess
one
pcp
autocatalyt
releas
ntermin
end
protein
nspl
orf
la
protein
ldv
prrsv
possess
two
pcp
releas
ntermin
product
kda
serin
proteinas
like
function
tran
seem
respons
process
orf
la
protein
orf
lb
protein
cultur
fix
aceton
sequenti
incub
plasma
ldvinfect
mice
fluorescein
isothiocyanateconjug
antimous
igg
electron
micrograph
b
show
perinuclear
area
doublemembran
vesicl
dmio
free
nucleocapsid
nc
nucleocapsid
bud
singlemembran
vesicl
arrow
golgi
membran
upper
left
side
infect
primari
cell
cultur
show
subpopul
macrophag
peritoneum
variou
tissu
mice
support
ldv
replic
signific
extent
ldvinfect
cell
recogn
presenc
viral
rna
viral
protein
infect
cell
see
fig
periton
macrophag
obtain
mice
variou
strain
product
infect
ldv
week
age
proport
permiss
macrophag
peritoneum
decreas
lower
level
level
permiss
macrophag
peritoneum
decreas
adult
mice
maintain
pathogenfre
condit
maintain
condit
like
consequ
inappar
infect
mous
hepat
viru
even
plagemann
unpublish
data
replic
ldv
permiss
macrophag
rapid
cytocid
viral
rna
synthesi
begin
h
pi
maximum
viru
produc
h
pi
yield
infecti
unit
idso
cell
cell
death
ensu
soon
thereaft
fluoresc
antibodi
stain
infect
macrophag
electron
microscop
examin
section
infect
ceil
indic
product
accumul
ldv
protein
viru
matur
larg
restrict
perinuclear
region
fig
b
respect
first
sign
infect
macrophag
format
cluster
free
membranebound
polyribosom
region
well
doublemembran
vesicl
nm
diamet
see
fig
h
pi
follow
abund
format
nucleocapsid
core
matur
virion
bud
singlemembran
vesicl
gener
area
adjac
cluster
accumul
doublemembran
vesicl
close
golgi
membran
fig
present
hypothesi
concern
synthesi
virion
envelop
protein
viru
matur
follow
synthes
rough
endoplasm
reticulum
er
signal
peptid
remov
lumen
er
vesicl
becom
core
glycosyl
disulfid
bond
fig
protein
heterodim
travers
golgi
complex
wherebi
oligosaccharid
side
chain
process
convert
complex
oligosaccharid
virion
nucleocapsid
bud
vesicl
carri
heterodim
releas
tran
cisterna
golgi
complex
see
fig
vesicl
fuse
cytoplasm
membran
unusu
basic
endodomain
virus
pi
may
play
import
role
viru
matur
might
interact
virion
rna
probabl
access
nucleocapsid
core
sinc
virion
rna
highli
sensit
degrad
rnase
isol
nucleocapsid
orf
protein
see
fig
probabl
synthes
via
rout
heterodim
work
eav
shown
gs
form
disulfidelink
homodim
present
virion
densiti
glm
heterodim
two
present
similar
amount
infect
cell
potenti
function
orf
protein
present
low
densiti
envelop
viru
replic
unknown
origin
doublemembran
vesicl
potenti
function
viru
replic
also
unknown
mode
viru
releas
cell
like
occur
via
movement
viruscontain
vesicl
plasma
membran
follow
exocytosi
numer
cell
line
includ
mani
mous
macrophag
cell
line
shown
support
ldv
replic
appar
lack
surfac
compon
function
ldv
receptor
sinc
resist
cell
line
product
transfect
ldv
rna
infect
via
mous
hepat
viru
mhv
receptor
pseudotyp
virion
mhv
ldv
ldv
infect
permiss
mous
macrophag
seem
involv
receptormedi
endocytosi
probabl
via
receptor
express
specif
stage
differenti
ident
receptor
unknown
lack
permiss
cell
line
ldv
quantit
endpoint
dilut
assay
mice
base
increas
plasma
ldh
activ
accompani
ldv
infect
mice
mice
macrophag
appear
primari
sole
type
cell
support
ldv
replic
immunocytochem
stain
situ
hybrid
shown
day
pi
ldvinfect
ceil
present
practic
tissu
especi
macrophagerich
locat
exampl
greatest
number
infect
cell
present
lymph
node
spleen
skin
lung
leptomening
central
nervou
system
cn
lymph
node
ldvinfect
cell
locat
margin
zone
paracortex
capsul
fig
b
spleen
mainli
locat
margin
zone
red
white
pulp
fig
cn
ldvinfect
cell
restrict
leptomening
upon
primari
infect
mous
ldv
product
infect
permiss
macrophag
estim
cellsmous
within
first
day
pi
plasma
ldv
titer
reach
day
pi
thereaft
plasma
ldv
titer
decreas
progress
next
week
constant
level
vari
mous
strain
persist
life
mous
along
elev
plasma
ldh
activ
day
pi
practic
permiss
ceil
destroy
persist
infect
maintain
replic
ldv
new
permiss
macrophag
continu
slowli
regener
appar
nonpermiss
precursor
cell
recent
situ
hybrid
studi
consist
detect
low
constant
number
ldvinfect
cell
liver
paracortex
lymph
node
margin
zone
spleen
test
persist
infect
mice
day
pi
anoth
tissu
ldv
replic
persist
seem
thymu
seem
primari
organ
new
ldvpermiss
macrophag
aris
local
sinc
infect
cell
detect
tissu
persist
infect
mice
addit
low
number
ldvinfect
cell
lymph
node
spleen
situ
hybrid
demonstr
accumul
larg
amount
ldv
rna
germin
center
tissu
eg
fig
f
begin
form
within
day
pi
diffus
distribut
ldv
rna
suggest
associ
ldv
virion
becom
trap
perhap
mainli
immun
complex
see
follicular
dendrit
cell
fdc
present
light
zone
germin
center
fig
f
format
germin
center
accumul
ldv
virion
within
coincid
format
antildv
antibodi
polyclon
activ
b
cell
reflect
elev
plasma
appear
low
molecular
weight
immun
complex
circul
fig
see
section
wash
coat
photograph
emuls
expos
stain
hematoxylin
eosin
arrow
indic
ldvinfect
cell
accumul
ldv
rna
b
f
darkfield
imag
microscop
field
bright
field
imag
shown
c
e
mz
margin
zone
pc
paracortex
rp
wp
red
white
pulp
respect
gc
germin
center
af
failur
antildv
immun
respons
control
ldv
replic
ldv
replic
macrophag
seem
impervi
host
defens
normal
oper
control
viru
infect
failur
immun
system
control
ldv
infect
indic
find
time
cours
level
viremia
nude
mice
fail
mount
antildv
immun
respons
well
mice
render
immunotoler
infect
newborn
immunocompet
litterm
immunotoler
seem
maintain
life
mous
probabl
result
continu
gener
ldv
antigen
thymu
see
persist
phase
infect
ldv
replic
thu
viremia
seem
control
rate
regener
permiss
macrophag
rather
immun
respons
conclus
support
find
treatment
stimul
macrophag
gener
enhanc
viremia
persist
infect
antildv
antibodi
ee
fluoresc
antibodi
titrat
assay
total
aa
captur
elisa
immun
complex
xx
bind
elisa
plate
coat
antigen
compos
data
question
aris
continu
ldv
replic
escap
host
defens
reason
entir
resolv
none
normal
defens
play
role
protect
andor
recoveri
viral
infect
interferoncdfl
ifnafl
antivir
antibodi
cytotox
cell
ctl
effect
control
ldv
infect
larg
amount
ifncfl
becom
transient
gener
infect
mice
day
pi
probabl
produc
larg
number
macrophag
becom
infect
time
period
howev
ldv
replic
macrophag
rel
resist
furthermor
ifncdfl
detect
circul
persist
infect
mice
thu
amount
produc
seem
low
effect
ldv
replic
antivir
antibodi
normal
play
role
antivir
defens
neutral
viral
infect
antibodydepend
complement
lysi
virion
antibodydepend
cellmedi
cytotox
adcc
howev
antildv
antibodi
though
effici
gener
high
titer
ineffectu
prevent
suppress
ldv
infect
antildv
antibodi
begin
appear
day
pi
reach
maximum
level
week
pi
fig
antibodi
direct
mainli
primari
envelop
glycoprotein
mainli
isotyp
earli
antibodi
fail
neutral
ldv
infect
neutral
measur
incub
virion
antibodi
vitro
titrat
residu
infect
mice
antibodi
neutral
ldv
condit
appear
mice
month
pi
neutral
ldv
infect
vitro
rel
poorli
latter
also
case
monoclon
antibodi
envelop
glycoprotein
although
certain
antibodi
neutral
ldv
infect
vitro
mention
alreadi
signific
effect
cours
infect
vivo
fig
find
also
indic
adcc
play
role
control
ldv
replic
furthermor
passiv
immun
polyclon
monoclon
neutral
antibodi
provid
protect
mice
ldv
infect
affect
level
viremia
persist
infect
mice
vitro
neutral
ldv
observ
high
antibodi
concentr
associ
increas
sediment
rate
virion
result
indic
bind
antibodi
virion
ineffici
vitro
neutral
requir
bind
multipl
antibodi
molecul
per
virion
addit
vitro
neutral
affect
complement
even
though
mani
antildv
polyclon
monoclon
antibodi
isotyp
effici
bind
complement
unclear
antildv
antibodi
ineffici
vitro
even
vivo
neutral
ldv
infect
ineffici
could
relat
uniqu
structur
virion
envelop
protein
fig
amino
acid
amino
acid
seem
expos
virion
surfac
ectodomain
seem
small
react
antibodi
overal
protein
seem
possess
low
immunogen
antibodi
detect
infect
mice
among
sever
batteri
monoclon
antibodi
ectodomain
also
small
probabl
possess
limit
number
neutral
epitop
five
neutral
monoclon
antibodi
gener
one
set
monoclon
antibodi
react
singl
epitop
limit
size
ectodomain
may
provid
littl
space
interact
antibodi
may
imped
larg
polylactosaminoglycan
side
chain
disulfid
linkag
protein
form
viru
attach
site
exampl
shown
singl
polylactosaminoglycan
nb
protein
influenza
b
viru
mask
ntermin
end
protein
antibodi
recognit
nevertheless
throughout
persist
infect
practic
virion
circul
associ
antibodi
immun
complex
ldv
infect
partial
neutral
antimous
igg
may
becom
trap
fdc
germin
center
see
virionantibodi
immun
complex
differ
low
molecular
immun
complex
form
associ
polyclon
activ
b
cell
induc
ldv
infect
see
situat
antildv
antibodi
inhibit
ldv
infect
block
transplacent
ldv
transmiss
paralyt
infect
akr
mice
latter
mice
possess
least
one
endogen
replicationcompet
ecotrop
murin
leukemia
viru
mulv
nn
genotyp
express
ecotrop
mulv
cn
glial
cell
render
anterior
horn
neuron
suscept
cytocid
infect
neurovirul
strain
ldv
ecotrop
mulv
express
induc
ldv
permiss
anterior
horn
neuron
make
ldv
permiss
unclear
one
like
possibl
ldv
permiss
motor
neuron
due
express
novel
surfac
compon
cell
function
altern
receptor
neurovirul
strain
ldv
destruct
motor
neuron
ldv
infect
lead
fatal
paralysi
week
pi
howev
neutral
nonneutr
antildv
antibodi
block
paralyt
ldv
infect
either
prevent
ldv
enter
cn
block
motor
neuron
infect
motor
neuron
protect
antildv
antibodi
effect
without
interfer
ldv
replic
macrophag
ctl
play
primari
role
recoveri
mani
viral
infect
lyse
infect
cell
present
viral
peptid
class
mhc
molecul
recent
demonstr
nvplspecif
ctl
becom
rapidli
gener
ldvinfect
mice
disappear
day
pi
two
set
target
cell
use
ldvinfect
cultur
macrophag
pathogenfre
mice
kbd
cell
infect
mulv
vector
lxsn
carri
ldv
orf
encod
n
protein
spleen
cell
isol
mice
swiss
mice
time
pi
ldv
fail
lyse
target
cell
howev
spleen
cell
ldvinfect
b
swiss
mice
expos
ldvinfect
b
macrophag
cell
respect
cultur
presenc
cell
becam
amplifi
lyse
target
cell
manner
fig
exampl
ctl
swiss
mice
lyse
cell
ldvinfect
macrophag
wherea
opposit
case
ctl
mice
ctl
swiss
x
hybrid
mice
sa
lyse
target
cell
wherea
cell
infect
mulv
vector
carri
orf
wrong
orient
express
well
uninfect
macrophag
mice
lyse
ctl
yet
detect
either
swiss
mice
day
pi
ctl
becam
amplifi
upon
cultur
spleen
cell
mice
less
effici
spleen
mice
day
pi
ctl
precursor
detect
anymor
reason
disappear
ctl
probabl
clonal
exhaust
regardless
even
ctl
present
littl
effect
ldv
replic
mice
indic
discuss
alreadi
find
ldv
viremia
nude
mice
immunocompet
litterm
lack
ctl
effect
confirm
induc
primari
secondari
ctl
respons
swiss
mice
inject
cell
express
ldv
challeng
mice
ldv
inject
swiss
mice
cell
induc
primari
ctl
respons
day
inject
subsid
day
inject
cell
transient
secondari
ctl
respons
induc
second
inject
cell
time
inject
mice
either
primari
secondari
ctl
respons
ldv
reduc
ldv
replic
one
loglo
transient
constant
level
viremia
persist
phase
infect
fig
repres
steadyst
rate
ldv
product
clearanc
infecti
viru
circul
ldv
product
depend
continu
round
de
novo
infect
permiss
cell
sinc
product
infect
cell
die
within
day
pi
rate
ldv
product
function
rate
gener
new
ldvpermiss
macrophag
mechan
loss
infecti
ldv
circul
less
clear
howev
sinc
antildv
immun
respons
seem
play
arol
ldv
clearanc
loss
infecti
ldv
probabl
mainli
consequ
physic
inactiv
conclus
support
find
initi
loss
infecti
viru
day
pi
begin
mous
mount
signific
antildv
immun
respons
singlehit
process
fig
halflif
ldv
loss
similar
observ
ldv
inactiv
vitro
earli
stage
infect
product
ldv
infect
newli
gener
permiss
macrophag
insignific
rel
overal
plasma
ldv
titer
howev
eventu
steadi
state
viru
product
physic
inactiv
reach
basi
consider
estim
infect
new
permiss
macrophagesday
seem
suffici
account
observ
level
persist
viremia
fig
ldv
infect
mice
shortterm
longterm
effect
host
immun
system
none
seem
signific
effect
health
host
initi
infect
result
transient
suppress
cellular
immun
respons
reflect
increas
surviv
tissu
tumor
transplant
reduc
delayedtyp
hypersensit
lipopolysaccharideinduc
inflammatori
respons
experiment
allerg
enceph
induc
mice
inject
myelin
basic
protein
suppress
cellular
immun
respons
correl
time
transient
decreas
thymu
weight
impair
prolif
respons
spleen
cell
vitro
concanavalin
con
fig
antibodi
impair
abil
cell
produc
effect
normal
associ
cell
anergi
unpublish
data
mechan
effect
caus
ldv
infect
elucid
may
multipl
caus
effect
may
trigger
cytokin
releas
larg
number
macrophag
becom
initi
product
infect
also
implic
factor
suppress
immun
function
nitric
oxid
produc
activ
residu
macrophag
could
one
factor
suppress
cell
result
support
suggest
found
residu
periton
macrophag
present
ldvinfect
mice
possess
sevenfoldincreas
capac
produc
express
capac
cultur
macrophag
seem
partial
activ
insuffici
ifn
gener
stage
infect
see
induc
product
cell
even
later
infect
amount
ifnmay
low
local
induc
signific
product
macrophag
contrast
transient
suppress
cellular
immun
respons
week
pi
humor
antibodi
respons
celldepend
independ
antigen
enhanc
time
period
enhanc
antibodi
respons
inject
antigen
correl
nonspecif
polyclon
activ
b
cell
progress
enhanc
persist
product
polyclon
mice
correl
format
ldv
antibodi
polyclon
activ
b
cell
fig
increas
specif
antibodi
respons
gener
germin
center
accumul
ldv
germin
center
suggest
observ
causal
relat
also
associ
hyperplasia
lymph
node
splenomegali
latter
seem
partli
due
trap
lymphocyt
erythrocyt
also
probabl
partli
prolifer
b
cell
antildv
antibodi
respons
polyclon
activ
b
cell
celldepend
process
furthermor
polyclon
activ
b
cell
occur
mice
activ
infect
ldv
mice
immun
inactiv
ldv
polyclon
activ
b
ceil
appar
spontan
prolifer
product
spleen
b
cell
ldvinfect
mice
isol
celldeplet
mice
b
cell
also
prolifer
spontan
fail
produc
unless
cultur
presenc
agreement
current
model
b
cell
respons
combin
data
summar
suggest
occurr
follow
relat
event
first
day
pi
ldv
ldv
protein
may
function
gener
b
cell
mitogen
perhap
combin
produc
ldvinfect
macrophag
activ
b
cell
spleen
lymph
node
ldv
antigen
produc
larg
amount
spleen
lymph
node
close
associ
follicl
see
fig
induc
format
germin
center
ldv
becom
trap
fdc
addit
b
cell
becom
activ
trap
ldv
antigen
process
ldv
antigen
present
cell
becom
activ
interact
cell
ldvspecif
b
cell
result
product
antildv
antibodi
wherea
polyclon
activ
b
cell
differenti
plasma
cell
respons
produc
activ
thl
cell
ifn
also
probabl
produc
ldvspecif
ctl
rapidli
induc
lymphoid
tissu
see
agreement
scenario
spleen
cell
ldvinfect
mice
shown
produc
increas
amount
ifn
respons
con
fig
produc
increas
amount
ifn
latent
period
h
product
begin
exposur
con
observ
spleen
cell
uninfect
mice
abolish
spleen
spleen
cell
harvest
group
two
mice
indic
time
pi
ldv
cultur
triplic
tissu
cultur
plate
cell
mediumwel
wellswer
supplement
con
aml
day
incub
ad
well
anoth
h
incub
cell
analyz
radioact
unpublish
data
rowland
plagemann
cell
ldvinfect
mice
fig
find
suggest
spleen
cell
ldvinfect
mice
contain
preform
mrna
conclus
confirm
northern
hybrid
analys
total
spleen
rna
spleen
ldvinfect
mice
contain
mrna
wherea
none
detect
spleen
uninfect
mice
unpublish
data
opposit
case
mrna
unpublish
data
polyclon
activ
b
cell
infect
mice
associ
format
autoantibodi
exhibit
wide
rang
specif
well
appear
low
level
contain
hydrophob
immun
complex
latter
like
consist
autoantibodi
cellular
antigen
sinc
contain
igg
isotyp
produc
polyclon
repres
complex
ldv
antigen
antibodi
sinc
produc
mice
antildv
antibodi
produc
persist
phase
infect
ldv
primari
secondari
humor
antibodi
respons
slightli
suppress
effect
could
due
ifn
suppress
cell
function
cytokin
product
two
ldv
strain
whose
genom
sequenc
isol
laboratori
mice
carri
differ
ldvcontamin
transplant
mous
tumor
origin
ldv
unknown
probabl
origin
ldv
endem
wild
hous
mous
mu
musculu
domesticu
popul
ldv
isol
wild
hous
mice
europ
usa
australia
howev
mice
wild
infect
probabl
ldv
transmiss
mice
rel
ineffici
spite
lifelong
rel
high
viremia
infect
mice
secret
viru
urin
fece
saliva
horizont
transmiss
mice
seem
restrict
mucos
barrier
sinc
infect
mice
ldv
via
oral
vagin
rectal
ocular
rout
requir
four
six
order
magnitud
higher
amount
ldv
via
inject
intranas
infect
achiev
plagemann
cafruni
unpublish
data
horizont
transmiss
observ
laboratori
mice
fight
bite
role
rout
transmiss
play
wild
unclear
possibl
ldv
maintain
wild
mous
popul
sexual
transmiss
need
studi
ldv
probabl
continu
secret
via
semen
persist
infect
male
see
ldv
highli
infecti
inject
regardless
rout
inject
one
mous
probabl
repres
virion
particl
ldv
transmit
mother
offspr
transplacent
via
breast
milk
mother
mount
antildv
immun
respons
antildv
antibodi
block
transplacent
transmiss
viru
releas
milk
ldv
eav
prrsv
shfv
structur
indistinguish
genom
organ
express
also
protein
eav
especi
prrsv
close
relat
ldv
size
amino
acid
sequenc
structur
see
fig
virus
share
properti
macrophag
primari
sole
host
cell
growth
cycl
mode
replic
cytopathogen
cell
compar
establish
persist
infect
host
eav
prrsv
transmit
sexual
via
semen
transplacent
mother
offspr
howev
mark
differ
pathogen
exist
eav
prrsv
similarli
caus
respiratori
reproduct
failur
host
contrast
shfv
establish
asymptomat
persist
infect
sever
genera
african
monkey
ldv
mice
accident
transmiss
shfv
asian
macaqu
monkey
monkey
coloni
result
fatal
hemorrhag
fever
transmiss
macaqu
monkey
via
respiratori
rout
transmiss
eav
prrsv
epizoot
wherea
rout
transmiss
observ
ldv
furthermor
contrast
persist
ldv
infect
antivir
antibodi
level
gener
low
nonexist
african
monkey
persist
infect
shfv
shfv
eav
prrsv
infect
seem
suppress
antivir
immun
respons
eav
prrsv
infect
gener
antivir
immun
respons
correl
termin
viremia
vaccin
effect
protect
hors
eav
infect
reason
differ
effect
host
immun
system
control
eav
prrsv
infect
ldv
infect
unclear
case
spite
antivir
immun
respons
eav
prrsv
replic
may
persist
tissu
especi
testi
fact
persist
infect
stallion
boar
common
sourc
new
infect
continu
viru
replic
test
may
maintain
infect
newli
gener
permiss
macrophag
alreadi
describ
ldv
ldv
contradict
commonli
held
view
mechan
viru
persist
name
persist
primarili
associ
noncytopath
virus
select
immun
escap
variant
mutant
decreas
express
certain
viral
protein
infect
cell
replic
immuneprivileg
site
gener
suppress
host
immun
system
etc
ldv
highli
cytocid
viru
invari
establish
lifelong
virem
persist
mice
spite
normal
antivir
immun
respons
one
secret
ldv
success
persist
specif
renew
nonessenti
popul
cell
continu
regener
name
subpopul
macrophag
sinc
continu
destruct
cell
associ
obviou
health
effect
macrophag
popul
seem
nonessenti
wellb
host
function
identifi
subpopul
macrophag
clearanc
muscl
type
ldh
enzym
furthermor
effect
ldv
infect
host
immun
system
name
polyclon
activ
b
cell
associ
product
autoantibodi
slight
impair
primari
secondari
antibodi
respons
also
seem
sever
enough
caus
clinic
consequ
ldv
replic
macrophag
escap
host
defens
persist
depend
selet
immun
escap
variant
mutant
palmer
even
plagemann
unpublish
result
also
ldv
replic
restrict
immuneprivileg
site
ldv
replic
persist
liver
lymphoid
tissu
testi
latter
could
consid
site
readili
access
immun
surveil
like
resist
ldv
replic
antivir
immun
respons
relat
uniqu
structur
envelop
protein
product
larg
quantiti
viral
antigen
high
titer
antildv
antibodi
gener
infect
mice
neutral
ldv
infect
ineffici
even
though
antivir
antibodi
mainli
isotyp
mediat
complement
lyse
virion
interact
antibodi
complement
heterodim
viral
envelop
may
imped
exposur
short
peptid
segment
protein
envelop
surfac
presenc
larg
oligosaccharid
side
chain
furthermor
sinc
ldv
matur
restrict
intracytoplasm
cisterna
question
aris
whether
viral
protein
avail
surfac
infect
cell
adcc
ctl
also
fail
control
ldv
replic
altough
ctl
specif
rapidli
gener
disappear
day
pi
reason
loss
unknown
highdos
clonal
exhaust
reason
possibl
sinc
regardless
infecti
dose
larg
amount
ldv
protein
present
lymphoid
tissu
time
induct
ctl
respons
furthermor
exhaust
ctl
peripheri
continu
replic
ldv
thymu
assur
mice
becom
perman
immunolog
toler
respect
ldv
antigenspecif
ctl
result
neg
select
thymu
ldv
might
primari
exampl
effect
perman
clonal
ctl
delet
adult
anim
natur
condit
infect
presum
mode
transmiss
ldv
natur
event
associ
infect
mice
strikingli
similar
observ
acut
asymptomat
phase
infect
human
immunodefici
viru
hiv
includ
primari
ineffici
transmiss
via
sexual
transplacent
rout
effect
transmiss
via
blood
primari
replic
renew
popul
lymphoid
cell
product
larg
amount
viru
initi
infect
host
follow
persist
low
level
viremia
spite
antivir
immun
respons
persist
reflect
continu
round
product
cytocid
infect
permiss
cell
rate
gener
permiss
cell
may
main
factor
determin
level
viru
product
case
hiv
rate
activ
cell
support
product
hiv
replic
might
factor
determin
rate
viru
product
progress
diseas
rapid
antibodi
format
delay
product
neutral
antibodi
limit
neutral
capac
rapid
transient
gener
virusspecif
ctl
accumul
larg
amount
viru
newli
form
germin
center
spleen
lymph
node
concomit
initi
perman
polyclon
activ
b
cell
result
elev
plasma
event
describ
point
might
gener
associ
natur
virem
persist
viru
infect
persist
virus
necess
evolv
properti
allow
escap
host
defens
control
infect
immunolog
process
therefor
difficult
imposs
prevent
infect
chemotherapi
may
approach
avail
combat
viru
infect
